Spren provides a camera-enabled, digital biomarker platform that lets health, wellness, and fitness companies embed biomarker insights (HRV, body composition, stress, recovery, cardiovascular fitness, and more) into their apps via an SDK and API. The technology transforms smartphones into real-time biomarker sensors without additional hardware or wearables. Spren builds on the Elite HRV app (715,000+ users) and is rolling out integrations with partners including Fitbod, Marius Pharmaceuticals, FORTË, and Final Surge. Its patented algorithms are supported by research collaborations with 117 universities and analysis of more than four billion biomarkers across 20 million user sessions. The company aims to accelerate enterprise integrations and expand into the broader $1.5 trillion global wellness market. The seed financing announced in October 2022 is intended to fund product expansion and partner rollouts.

Total raised

$11M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2022